Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.050
+0.040 (1.00%)
At close: Apr 6, 2026, 4:00 PM EDT
4.140
+0.090 (2.22%)
After-hours: Apr 6, 2026, 4:23 PM EDT

Coya Therapeutics Revenue

In the year 2025, Coya Therapeutics had annual revenue of $7.95M with 123.57% growth. Coya Therapeutics had revenue of $3.96M in the quarter ending December 31, 2025, with 202,768.80% growth.

Revenue (ttm)
$7.95M
Revenue Growth
+123.57%
P/S Ratio
11.96
Revenue / Employee
$993,219
Employees
8
Market Cap
95.00M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.95M4.39M123.57%
Dec 31, 20243.55M-2.45M-40.79%
Dec 31, 20236.00M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Q32 Bio53.74M
Verrica Pharmaceuticals35.58M
Seer, Inc.16.58M
Pyxis Oncology13.86M
Seres Therapeutics789.00K
Spruce Biosciences697.00K
Revenue Rankings